Browsing Tag

Special Reports

58 posts

DCAT Week ’17 Member Company Announcement Forum: Tracking the Pharma Manufacturing Value Chain
By

By
Senior executives from member companies of the Drug, Chemical & Associated Technologies Association (DCAT) highlighted key strategic activity, including mergers and acquisitions (M&A), post-M&A integration, and manufacturing expansions, at the…

DCAT Week ’17: Novasep Opens New Bioconjugation Facility for ADCs
By

By
Kevin DaleyDirector, Pharmaceuticals Novasep Kevin Daley, Director, Pharmaceuticals, Novasep, highlighted the opening of the company’s new EUR 11 million ($11 million) bioconjugation facility, in Le Mans France, at the DCAT…

DCAT Week ’17 Announcement Forum: Siegfried CEO Outlines Five-Year Strategic Plan
By

By
Rudolf Hanko, PhD CEO, Siegfried AG Rudolf Hanko, PhD, Chief Executive Officer of Siegfried AG, a contract manufacturer of both drug substances and drug products, outlined the company’s five-year plan for…

DCAT Week ’17 Announcement Forum: Patheon Discusses Acquisition of Former Roche API Manufacturing Facility
By

By
Andreas Stolle, PhD Vice President, API Process Development ServicesPatheon Andreas Stolle, PhD, Vice President, API Process Development Services, Patheon, discussed how the company is integrating its most recent acquisition into…

DCAT Week ’17 Announcement Forum: Olon Highlights Integration of Infa
By

By
Giorgio BertoliniSenior Vice President, Research & Development, Chemistry, Olon S.p.A. Giorgio Bertolini, Senior Vice President, Research & Development, Chemistry. Olon S.p.A, outlined the integration of the Infa Group, which Olon…

DCAT Week ’17: Noramco CEO Discusses Strategy as Stand-Alone Company
By

By
James MishPresident & CEO Noramco James Mish, President and CEO of Noramco, provided the strategic direction of the company following its divestment by Johnson & Johnson in July 2016 and…

DCAT Week ’17 Announcement Forum: Mayne Pharma Specifies Timeline for $80-Million Expansion
By

By
Kimberly McClintock Executive Vice President, Metrics Contract Services Mayne Pharma Metrics Contract Services and its parent, Mayne Pharma, are constructing an $80-million commercial pharmaceutical manufacturing facility as part of a…

DCAT Week ’17 Announcement Forum: Datwyler Outlines $100-Million Manufacturing Expansion
By

By
Megan Williamson Vice President, Injection SystemsDatwyler The Datwyler Group is proceeding with a $100-million investment for a new manufacturing facility for elastomer components, outlined Megan Williamson, Vice President, Injection Systems, Datwyler…

DCAT Week ’17 Announcement Forum: Lubrizol’s Particle Sciences Proceeds With Manufacturing Expansion
By

By
Mark Mitchnick, MDCEOLubrizol’s Particle Sciences Mark Mitchnick, MD, Chief Executive Officer, Particle Sciences, a Lubrizol company, outlined the company’s recent investment in commercial manufacturing, the latest in a series of…

DCAT Week ’17 Announcement Forum: CordenPharma Expands Oligonucletide API and Sterile Injectables Manufacturing Capacity
By

By
Mimoun Ayoub, PhD Director, Global Peptides, Oligonucleotides, Lipids, Carbohydrates & Injectables Platforms CordenPharma Corden Pharma is expanding into oligonucleotide active pharmaceutical ingredient (API) manufacturing, which is supported by a growing clinical…